Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00682747Phase 2Terminated
Phase 2, randomised, open-label trial of hyperbaric oxygen therapy in radiation-induced xerostomia (2 arms). Primary endpoint: change of overall salivation at Day 146. Started May 2008; status: terminated.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00682747.